# A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-S

Source: https://onco.cc/trials/nct07464327/  
OnCo record `nct07464327` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of HS-20093 and docetaxel in lung cancer, run by Hansoh BioMedical R&D Company, not yet recruiting.

## Summary

A Phase III Study of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations is a phase 3, randomised interventional study registered as NCT07464327 by Hansoh BioMedical R&D Company, with a registry enrolment figure of 450 participants, started 2026-03-31 and due to reach its primary completion in 2028-12-31. Interventions recorded: HS-20093; Docetaxel. Conditions listed: Non-Small Cell Lung Cancer. Primary outcome: Progression-free survival (PFS) assessed by Blinded Independent Central Review (BICR); Overall survival (OS). Lung eligibility wording from the registry: "Previously treated patients with histologically or cytologically confirmed diagnosis of advanced or metastatic non-squamous non-small cell lung cancer (nsq-NSCLC)". No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT07464327
- Phase: 3
- Setting: A Multicenter, Randomized, Open-Label, Controlled Phase III Clinical Study Evaluating the Efficacy and Safety of HS-20093 Injection Combined With Adebrelimab Versus Docetaxel in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations
- Sponsor: Hansoh BioMedical R&D Company
- Enrolled: 450

## Sources

- ClinicalTrials.gov NCT07464327: https://clinicaltrials.gov/study/NCT07464327

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/)
- drugs: [Docetaxel](https://onco.cc/drugs/docetaxel/), [HS-20093](https://onco.cc/drugs/hs-20093/)
- companies: [Hansoh Pharmaceutical](https://onco.cc/companies/hansoh-pharma/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct07464327.json